• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Nuclear Imaging Market

    ID: MRFR/HC/41425-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Nuclear Imaging Market Research Report By Application (Cardiology, Oncology, Neurology, Gastroenterology, Orthopedics), By Type of Imaging Technique (Single Photon Emission Computed Tomography, Positron Emission Tomography, Hybrid Imaging Techniques), By End Use (Hospitals, Diagnostic Imaging Centers, Research Institutions, Home Healthcare), By Technology (Gamma Cameras, SPECT Systems, PET Systems) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Nuclear Imaging Market Infographic
    Purchase Options

    Nuclear Imaging Market Summary

    As per MRFR analysis, the Nuclear Imaging Market Size was estimated at 2.88 USD Billion in 2024. The Nuclear Imaging industry is projected to grow from 2.999 USD Billion in 2025 to 4.5 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.14 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Nuclear Imaging Market is poised for substantial growth driven by technological advancements and increasing demand for diagnostics.

    • North America remains the largest market for nuclear imaging, driven by advanced healthcare infrastructure and technology.
    • The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and a focus on early diagnosis.
    • Cardiology continues to dominate as the largest segment, while oncology is rapidly gaining traction as the fastest-growing area within nuclear imaging.
    • Technological advancements in imaging techniques and the rising incidence of chronic diseases are key drivers propelling market growth.

    Market Size & Forecast

    2024 Market Size 2.88 (USD Billion)
    2035 Market Size 4.5 (USD Billion)
    CAGR (2025 - 2035) 4.14%

    Major Players

    Siemens Healthineers (DE), GE Healthcare (US), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), Hologic (US), Bracco Imaging (IT), Lantheus Medical Imaging (US)

    Nuclear Imaging Market Trends

    The Nuclear Imaging Market is currently experiencing a transformative phase, characterized by advancements in technology and increasing demand for precise diagnostic tools. Innovations in imaging modalities, such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET), are enhancing the accuracy of disease detection and monitoring. Furthermore, the integration of artificial intelligence and machine learning into imaging systems appears to be streamlining workflows and improving diagnostic capabilities. This evolution is likely to foster greater collaboration between healthcare providers and technology developers, ultimately benefiting patient outcomes. In addition to technological advancements, the Nuclear Imaging Market is influenced by a growing emphasis on personalized medicine. As healthcare shifts towards tailored treatment plans, the role of nuclear imaging in identifying specific patient needs becomes increasingly vital. This trend suggests a potential expansion of applications in oncology, cardiology, and neurology, where precise imaging can guide therapeutic decisions. Moreover, the rising prevalence of chronic diseases and an aging population may further drive the demand for nuclear imaging services, indicating a robust future for this sector.

    Technological Advancements

    The Nuclear Imaging Market is witnessing rapid technological progress, particularly in imaging modalities. Innovations such as SPECT and PET are enhancing diagnostic accuracy, while the incorporation of artificial intelligence is streamlining processes and improving outcomes.

    Personalized Medicine

    There is a notable shift towards personalized medicine within the Nuclear Imaging Market. This trend emphasizes tailored treatment plans, with nuclear imaging playing a crucial role in identifying specific patient needs, particularly in oncology and cardiology.

    Growing Demand for Diagnostics

    The demand for nuclear imaging services is on the rise, driven by an increasing prevalence of chronic diseases and an aging population. This trend indicates a robust future for the Nuclear Imaging Market, as healthcare systems seek effective diagnostic solutions.

    The Global Nuclear Imaging Market is poised for growth, driven by advancements in technology and an increasing demand for early disease detection and personalized medicine.

    U.S. Food and Drug Administration (FDA)

    Nuclear Imaging Market Drivers

    Growing Awareness of Early Diagnosis

    The Nuclear Imaging Market is also propelled by the growing awareness of the importance of early diagnosis among patients and healthcare providers. Educational campaigns and initiatives aimed at promoting preventive healthcare are leading to increased utilization of nuclear imaging techniques. As patients become more informed about the benefits of early detection, the demand for nuclear imaging services is likely to rise. Studies indicate that early diagnosis can significantly improve treatment outcomes, particularly in oncology. This heightened awareness is expected to contribute to the expansion of the nuclear imaging market, as more individuals seek out advanced diagnostic options.

    Rising Incidence of Chronic Diseases

    The Nuclear Imaging Market is significantly influenced by the rising incidence of chronic diseases, including cancer and cardiovascular disorders. As these conditions become more prevalent, the demand for effective diagnostic tools increases. Nuclear imaging plays a crucial role in the early detection and management of these diseases, allowing for timely interventions. Data indicates that the global burden of chronic diseases is expected to rise, with projections suggesting that by 2030, nearly 75% of deaths will be attributed to such conditions. This trend underscores the necessity for advanced imaging solutions, thereby propelling the growth of the nuclear imaging market.

    Aging Population and Healthcare Needs

    The Nuclear Imaging Market is significantly impacted by the aging population, which presents unique healthcare challenges. As individuals age, the prevalence of age-related diseases, such as Alzheimer's and other neurodegenerative disorders, increases. Nuclear imaging is essential for diagnosing and monitoring these conditions, thereby driving demand. Data suggests that by 2050, the number of people aged 65 and older will double, leading to a greater need for effective diagnostic tools. This demographic shift is likely to create substantial opportunities for growth within the nuclear imaging market, as healthcare systems adapt to meet the evolving needs of an aging population.

    Technological Advancements in Imaging Techniques

    The Nuclear Imaging Market is experiencing a surge in technological advancements that enhance imaging techniques. Innovations such as hybrid imaging systems, which combine modalities like PET and CT, are becoming increasingly prevalent. These advancements improve diagnostic accuracy and patient outcomes, thereby driving market growth. The integration of artificial intelligence in image analysis is also noteworthy, as it streamlines workflows and reduces interpretation errors. According to recent data, the market for nuclear imaging technologies is projected to grow at a compound annual growth rate of approximately 7.5% over the next few years. This growth is indicative of the industry's commitment to adopting cutting-edge technologies that facilitate better healthcare delivery.

    Increased Investment in Healthcare Infrastructure

    The Nuclear Imaging Market benefits from increased investment in healthcare infrastructure across various regions. Governments and private entities are allocating substantial resources to enhance healthcare facilities, which includes the procurement of advanced imaging technologies. This investment is particularly evident in emerging economies, where there is a concerted effort to improve diagnostic capabilities. Reports suggest that healthcare expenditure is expected to rise significantly, with many countries aiming to achieve universal health coverage. Such initiatives are likely to bolster the demand for nuclear imaging services, as healthcare providers seek to offer comprehensive diagnostic solutions.

    Market Segment Insights

    By Application: Cardiology (Largest) vs. Oncology (Fastest-Growing)

    In the Nuclear Imaging Market, cardiology represents the largest application segment, driven by the increasing prevalence of cardiovascular diseases and the growing number of diagnostic imaging procedures. Cardiac imaging plays a crucial role in patient management and is widely adopted in hospitals and outpatient facilities. Following closely, oncology is witnessing rapid growth, attributed to the rising incidence of cancer and advancements in imaging technologies that enhance cancer detection, treatment monitoring, and personalized therapy development. Oncology's remarkable growth can be linked to the increasing investments in cancer research and the development of radiopharmaceuticals. Furthermore, the adoption of hybrid imaging techniques combining nuclear imaging with other modalities is revolutionizing cancer diagnosis and treatment pathways. As healthcare providers focus on improving patient outcomes through early detection and effective treatment strategies, the demand for nuclear imaging in oncology will continue to surge, solidifying its position as a predominant application in the market.

    Cardiology (Dominant) vs. Neurology (Emerging)

    Cardiology stands out as a dominant application within the Nuclear Imaging Market, largely due to its established role in diagnosing and managing heart conditions. With advanced techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) being utilized widely, cardiology sees an extensive array of applications, from assessing myocardial perfusion to evaluating cardiac viability. On the other hand, neurology is emerging as a significant area in the market, driven by the increasing recognition of neurological disorders and the demand for precise imaging solutions. Technologies that enable enhanced visualization of brain activity, along with innovations in radiotracers, are expanding the utility of nuclear imaging in detecting neurological diseases like Alzheimer's and Parkinson's disease. As research continues to evolve in this domain, neurology is positioned for considerable growth in the near future.

    By Type of Imaging Technique: Positron Emission Tomography (Largest) vs. Hybrid Imaging Techniques (Fastest-Growing)

    The Nuclear Imaging Market is dominated by Positron Emission Tomography (PET), which captures the largest market share due to its precise imaging capabilities that assist in early disease detection and treatment monitoring. Following PET, Single Photon Emission Computed Tomography (SPECT) holds a significant share but is gradually being overshadowed by emerging technologies such as hybrid imaging techniques, which combine modalities to improve diagnostic accuracy and patient outcomes. Hybrid imaging, such as PET/CT and SPECT/CT, is gaining traction due to its multifaceted imaging benefits, which enhance clinicians' ability to visualize disease progression and treatment response.

    Position: PET (Dominant) vs. Hybrid Imaging Techniques (Emerging)

    Positron Emission Tomography (PET) is recognized for its unparalleled ability to detect metabolic processes in tissues, making it a cornerstone in oncology, cardiology, and neurology diagnostics. Its dominance stems from its high sensitivity and specificity, leading to improved patient management. Meanwhile, hybrid imaging techniques, such as PET/CT and SPECT/CT, are emerging rapidly in the market. They offer complementary data from both anatomical and functional imaging, facilitating comprehensive evaluations of diseases. Their ability to combine CT for precise localization with the functional insights of PET or SPECT is driving their adoption, making them increasingly appealing in clinical settings.

    By End Use: Hospitals (Largest) vs. Diagnostic Imaging Centers (Fastest-Growing)

    In the Nuclear Imaging Market, hospitals emerge as the largest segment, leveraging their infrastructure, technological advancements, and diverse patient demographics to capture a significant share. Diagnostic imaging centers follow closely, representing a vital component of the overall market as they provide specialized imaging services that support both hospitals and research institutions. Their ability to offer targeted services plays a crucial role in the segmentation of end-use applications.

    Hospitals (Dominant) vs. Diagnostic Imaging Centers (Emerging)

    Hospitals continue to dominate the Nuclear Imaging Market due to their advanced resources, accessibility for a broad patient base, and collaborative operations with specialized diagnostic centers. They often serve as primary facilities for advanced imaging procedures and nuclear medicine applications. On the other hand, diagnostic imaging centers are emerging as a critical part of the industry, providing focused and rapid imaging services. Their growth is driven by increased demand for precise diagnostics, expanding outpatient care, and the rising prevalence of chronic diseases. Both segments complement each other, yet their market strategies differ significantly as hospitals focus on comprehensive care and imaging centers emphasize specialty services.

    By Technology: Gamma Cameras (Largest) vs. PET Systems (Fastest-Growing)

    In the Nuclear Imaging Market, Gamma Cameras currently hold the largest market share, largely due to their extensive usage in detecting and diagnosing various health conditions, particularly in cardiology. SPECT Systems follow closely, providing advanced imaging capabilities that have made them integral in nuclear medicine. PET Systems, while gaining ground, still represent a smaller portion of the market but are quickly becoming a key player due to their superior imaging quality and efficiency, especially in oncology.

    Technology: Gamma Cameras (Dominant) vs. PET Systems (Emerging)

    Gamma Cameras are the dominant technology in the Nuclear Imaging Market, extensively utilized for their ability to capture images quickly and non-invasively, contributing to their widespread acceptance among healthcare providers. Their importance in cardiac imaging and functional assessments underscores their essential role. On the other hand, PET Systems are emerging rapidly, thanks to their advanced imaging capabilities that allow for the detection of diseases at earlier stages. Their potential for better treatment planning in oncology is driving their adoption, resulting in increased investments and innovations in this technology.

    Get more detailed insights about Nuclear Imaging Market

    Regional Insights

    The Nuclear Imaging Market showcases significant regional variations, with North America holding the majority share valued at 1.2 USD Billion in 2024 and projected to rise to 1.9 USD Billion by 2035. This dominance can be attributed to advanced healthcare infrastructure and a high prevalence of chronic diseases requiring precise imaging techniques. Europe follows, with a valuation of 0.8 USD Billion in 2024, indicating a strong demand for innovative imaging solutions amid ongoing technological advancements.

    The APAC region is emerging rapidly, valued at 0.6 USD Billion in 2024, suggesting a growing adoption of nuclear imaging technologies driven by increasing healthcare investments and rising awareness.Meanwhile, South America and MEA present smaller markets, valued at 0.15 USD Billion and 0.13 USD Billion, respectively, in 2024, reflecting more limited healthcare access and technological penetration. However, these regions are poised for growth as they modernize their healthcare systems.

    Overall, the Nuclear Imaging Market segmentation highlights how regional developments, healthcare demands, and investments shape the industry landscape, presenting opportunities for growth and innovation across various global markets in the coming years.

    Nuclear Imaging Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Nuclear Imaging Market is a dynamic and rapidly evolving sector within the healthcare industry, driven by technological advancements and increasing demand for diagnostic imaging solutions. This market encompasses a range of applications, including oncology, cardiology, and neurology, leveraging nuclear imaging techniques such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET). Key players in this market are constantly innovating and expanding their product offerings to enhance diagnostic accuracy and patient outcomes.

     Competitive insights reveal a landscape where collaborations, mergers and acquisitions, and research and development efforts are pivotal in maintaining a competitive edge. The strategic positioning of companies, their market penetration initiatives, and their ability to respond to evolving healthcare needs significantly influence their success within the Nuclear Imaging Market.Radiometer stands out in the Nuclear Imaging Market through its strong commitment to delivering cutting-edge nuclear imaging solutions. The company's strengths lie in its robust research and development capabilities, which enable it to introduce innovative products that meet clinical demands.

    Radiometer is known for its advanced technologies that facilitate enhanced imaging results, thereby improving diagnostic accuracy. Its strong market presence is bolstered by strategic partnerships and collaborations, allowing Radiometer to expand its reach and strengthen customer relationships. 

    As healthcare systems worldwide focus on improving patient care and streamlining workflows, Radiometer's dedication to excellence positions it favorably to capitalize on emerging opportunities within the nuclear imaging domain.Hologic, a prominent player in the Nuclear Imaging Market, is recognized for its innovative contributions and comprehensive portfolio of imaging solutions. The company focuses on women's health but has extended its expertise to molecular imaging technologies that play a critical role in disease detection and monitoring. Hologic's strengths are evident in its advanced imaging systems that support accurate diagnosis and treatment planning.

    The company emphasizes user-friendly interfaces and reliability in its products, which enhances the overall experience for healthcare professionals.

    Furthermore, Hologic's commitment to clinical education and support empowers practitioners to utilize their systems effectively. With a solid reputation for quality and innovation, Hologic is poised to continue its leadership role within the nuclear imaging sector, adapting to the evolving landscape of healthcare demands and patient needs.

    Key Companies in the Nuclear Imaging Market market include

    Industry Developments

    • Q2 2024: Bracco Imaging Announces FDA Approval of New Cardiac PET Imaging Agent Bracco Imaging received FDA approval for its new cardiac PET imaging agent, designed to improve diagnostic accuracy for coronary artery disease. The approval marks a significant regulatory milestone for Bracco’s nuclear imaging portfolio.
    • Q2 2024: GE HealthCare Launches Omni Legend 32 PET/CT System GE HealthCare introduced the Omni Legend 32 PET/CT system, a next-generation nuclear imaging device aimed at enhancing image quality and workflow efficiency in clinical settings.
    • Q2 2024: Siemens Healthineers Receives CE Mark for Biograph Vision Quadra PET/CT Siemens Healthineers obtained CE Mark approval for its Biograph Vision Quadra PET/CT system, enabling expanded clinical use of the device across Europe.
    • Q3 2024: Curium Acquires IASON to Expand European Radiopharmaceutical Footprint Curium, a global leader in nuclear medicine, acquired IASON, an Austrian radiopharmaceutical company, to strengthen its presence in the European nuclear imaging market.
    • Q3 2024: Cardinal Health Opens New Radiopharmaceutical Manufacturing Facility in Texas Cardinal Health inaugurated a new manufacturing facility in Texas dedicated to producing radiopharmaceuticals for nuclear imaging, expanding its supply capabilities in the U.S.
    • Q3 2024: Eckert & Ziegler Signs Strategic Partnership with Telix Pharmaceuticals for Theranostic Imaging Eckert & Ziegler entered a strategic partnership with Telix Pharmaceuticals to co-develop and supply theranostic imaging agents for cancer diagnosis and treatment.
    • Q4 2024: GE HealthCare Announces $100 Million Investment in Nuclear Imaging R&D GE HealthCare committed $100 million to research and development in nuclear imaging technologies, aiming to accelerate innovation in PET and SPECT systems.
    • Q4 2024: Siemens Healthineers Wins Multi-Year Contract to Supply PET/CT Systems to NHS England Siemens Healthineers secured a multi-year contract to supply PET/CT systems to NHS England, supporting the expansion of nuclear imaging services in the UK.
    • Q1 2025: Cardinal Health Appoints New President of Nuclear & Precision Health Solutions Cardinal Health named a new president for its Nuclear & Precision Health Solutions division, signaling a leadership change to drive growth in the nuclear imaging sector.
    • Q1 2025: Telix Pharmaceuticals Raises $50 Million in Series C Funding to Advance Nuclear Imaging Pipeline Telix Pharmaceuticals completed a $50 million Series C funding round to support the development and commercialization of its nuclear imaging agents.
    • Q2 2025: Bracco Imaging Expands U.S. Operations with New Nuclear Medicine Distribution Center Bracco Imaging opened a new distribution center in the U.S. to improve logistics and supply chain efficiency for its nuclear medicine products.
    • Q2 2025: GE HealthCare and Cardinal Health Announce Joint Venture for Radiopharmaceutical Manufacturing GE HealthCare and Cardinal Health formed a joint venture to manufacture and distribute radiopharmaceuticals, aiming to meet growing demand for nuclear imaging agents.

    Future Outlook

    Nuclear Imaging Market Future Outlook

    The Nuclear Imaging Market is projected to grow at a 4.14% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of chronic diseases, and rising demand for early diagnosis.

    New opportunities lie in:

    • Development of portable nuclear imaging devices for remote diagnostics.
    • Expansion of AI-driven analytics for enhanced imaging interpretation.
    • Partnerships with healthcare providers for integrated imaging solutions.

    By 2035, the Nuclear Imaging Market is expected to achieve substantial growth, reflecting evolving healthcare needs.

    Market Segmentation

    Nuclear Imaging Market End Use Outlook

    • Hospitals
    • Diagnostic Imaging Centers
    • Research Institutions
    • Home Healthcare

    Nuclear Imaging Market Technology Outlook

    • Gamma Cameras
    • SPECT Systems
    • PET Systems

    Nuclear Imaging Market Application Outlook

    • Cardiology
    • Oncology
    • Neurology
    • Gastroenterology
    • Orthopedics

    Nuclear Imaging Market Type of Imaging Technique Outlook

    • Single Photon Emission Computed Tomography
    • Positron Emission Tomography
    • Hybrid Imaging Techniques

    Report Scope

    MARKET SIZE 20242.88(USD Billion)
    MARKET SIZE 20252.999(USD Billion)
    MARKET SIZE 20354.5(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)4.14% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesAdvancements in detector technology enhance diagnostic accuracy in the Nuclear Imaging Market.
    Key Market DynamicsTechnological advancements and regulatory changes drive innovation and competition in the Nuclear Imaging Market.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Leave a Comment

    FAQs

    What is the expected market size of the Global Nuclear Imaging Market in 2024?

    The Global Nuclear Imaging Market is expected to be valued at 2.88 USD Billion in 2024.

    What is the projected market growth rate from 2025 to 2035?

    The expected compound annual growth rate (CAGR) for the Global Nuclear Imaging Market is 4.14% from 2025 to 2035.

    Which region is expected to hold the largest market share in 2024?

    North America is expected to hold the largest market share, valued at 1.2 USD Billion in 2024.

    What will be the market value of the Oncology application in 2035?

    The market value of the Oncology application is projected to reach 1.39 USD Billion in 2035.

    Which key players are significant in the Global Nuclear Imaging Market?

    Major players include Siemens Healthineers, GE Healthcare, Philips, and Fujifilm, among others.

    What will the market size for the Cardiology application be in 2024?

    The market size for the Cardiology application is estimated at 1.04 USD Billion in 2024.

    How much is the APAC region expected to grow by 2035?

    The APAC region's market value is expected to grow to 1.0 USD Billion by 2035.

    What is the expected market value for Orthopedics in 2035?

    The expected market value for Orthopedics in 2035 is projected to be 0.32 USD Billion.

    What challenges might the Global Nuclear Imaging Market face?

    Challenges may include regulatory hurdles and competition among established players.

    What is the expected market size for the MEA region in 2035?

    The expected market size for the MEA region is projected to be 0.15 USD Billion in 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions